$PETS
PETMED EXPRESS INC

2017 Q4 Form 10-Q Financial Statement

#000143774918001323 Filed on January 30, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2016 Q4
Revenue $60.11M $52.87M
YoY Change 13.7% 3.8%
Cost Of Revenue $38.17M $36.22M
YoY Change 5.36% 5.98%
Gross Profit $21.94M $16.64M
YoY Change 31.85% -0.64%
Gross Profit Margin 36.51% 31.48%
Selling, General & Admin $9.940M $8.530M
YoY Change 16.53% -4.91%
% of Gross Profit 45.3% 51.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $532.0K $457.0K
YoY Change 16.41% 185.63%
% of Gross Profit 2.42% 2.75%
Operating Expenses $10.48M $8.988M
YoY Change 16.56% -1.56%
Operating Profit $11.47M $7.655M
YoY Change 49.81% 0.46%
Interest Expense $190.0K $40.00K
YoY Change 375.0% -33.33%
% of Operating Profit 1.66% 0.52%
Other Income/Expense, Net $456.0K $166.0K
YoY Change 174.7%
Pretax Income $11.92M $7.821M
YoY Change 52.46% 1.97%
Income Tax $2.860M $2.998M
% Of Pretax Income 23.99% 38.33%
Net Earnings $9.064M $4.823M
YoY Change 87.93% -1.37%
Net Earnings / Revenue 15.08% 9.12%
Basic Earnings Per Share $0.45 $0.24
Diluted Earnings Per Share $0.44 $0.24
COMMON SHARES
Basic Shares Outstanding 20.37M 20.25M
Diluted Shares Outstanding 20.43M 20.41M

Balance Sheet

Concept 2017 Q4 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.00M $47.90M
YoY Change 69.1% -23.6%
Cash & Equivalents $81.00M $47.90M
Short-Term Investments
Other Short-Term Assets $1.000M $2.400M
YoY Change -58.33% -22.58%
Inventory $21.90M $14.90M
Prepaid Expenses
Receivables $1.715M $1.500M
Other Receivables $0.00 $900.0K
Total Short-Term Assets $105.6M $67.70M
YoY Change 55.97% -21.64%
LONG-TERM ASSETS
Property, Plant & Equipment $29.14M $29.10M
YoY Change 0.13% 2325.0%
Goodwill
YoY Change
Intangibles $860.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $30.00M $29.90M
YoY Change 0.33% 1259.09%
TOTAL ASSETS
Total Short-Term Assets $105.6M $67.70M
Total Long-Term Assets $30.00M $29.90M
Total Assets $135.6M $97.60M
YoY Change 38.93% 10.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.43M $5.400M
YoY Change 130.11% 0.0%
Accrued Expenses $3.000M $2.500M
YoY Change 20.0% 8.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.93M $7.900M
YoY Change 215.62% 2.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $24.93M $7.900M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $25.61M $8.200M
YoY Change 212.32% 6.49%
SHAREHOLDERS EQUITY
Retained Earnings $101.3M
YoY Change
Common Stock $21.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $110.0M $89.40M
YoY Change
Total Liabilities & Shareholders Equity $135.6M $97.60M
YoY Change 38.93% 10.16%

Cashflow Statement

Concept 2017 Q4 2016 Q4
OPERATING ACTIVITIES
Net Income $9.064M $4.823M
YoY Change 87.93% -1.37%
Depreciation, Depletion And Amortization $532.0K $457.0K
YoY Change 16.41% 185.63%
Cash From Operating Activities $16.85M $3.850M
YoY Change 337.66% -55.23%
INVESTING ACTIVITIES
Capital Expenditures -$210.0K -$4.000M
YoY Change -94.75%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$210.0K -$4.000M
YoY Change -94.75% 19900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.070M -3.850M
YoY Change 5.71% 6.35%
NET CHANGE
Cash From Operating Activities 16.85M 3.850M
Cash From Investing Activities -210.0K -4.000M
Cash From Financing Activities -4.070M -3.850M
Net Change In Cash 12.57M -4.000M
YoY Change -414.25% -180.65%
FREE CASH FLOW
Cash From Operating Activities $16.85M $3.850M
Capital Expenditures -$210.0K -$4.000M
Free Cash Flow $17.06M $7.850M
YoY Change 117.32% -8.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3034000
CY2017Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2475000
pets Prepaid Property And Equipment In Current Assets
PrepaidPropertyAndEquipmentInCurrentAssets
pets Prepaid Property And Equipment In Current Assets
PrepaidPropertyAndEquipmentInCurrentAssets
863000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12426000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15221000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1715000
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1808000
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9474000
CY2017Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
659000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8664000
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6806000
CY2017Q4 us-gaap Advertising Expense
AdvertisingExpense
4126000
CY2016Q4 us-gaap Advertising Expense
AdvertisingExpense
3170000
us-gaap Advertising Expense
AdvertisingExpense
14944000
us-gaap Advertising Expense
AdvertisingExpense
13312000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
CY2017Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77600
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77600
CY2017Q4 us-gaap Assets
Assets
135591000
CY2017Q1 us-gaap Assets
Assets
112809000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
105593000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
81785000
CY2017Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
29998000
CY2017Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
31024000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80997000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58730000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37639000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47904000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22267000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10265000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2016Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.19
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.57
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20601000
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20526000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20601000
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20526000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
21000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
21000
CY2017Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9064000
CY2016Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4823000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27100000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16316000
CY2017Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
38166000
CY2016Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
36223000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
133590000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
128985000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-412000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1164000
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
676000
CY2017Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1088000
us-gaap Depreciation
Depreciation
1590000
us-gaap Depreciation
Depreciation
855000
CY2017Q4 us-gaap Depreciation
Depreciation
532000
CY2016Q4 us-gaap Depreciation
Depreciation
457000
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2017Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.24
CY2016Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.383
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.311
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.375
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.315
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
115000
CY2017Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
47000
CY2016Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
145000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
90000
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5818000
CY2016Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5361000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18222000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17206000
CY2017Q4 us-gaap Gross Profit
GrossProfit
21944000
CY2016Q4 us-gaap Gross Profit
GrossProfit
16643000
us-gaap Gross Profit
GrossProfit
72888000
us-gaap Gross Profit
GrossProfit
57159000
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11924000
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7821000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39304000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26088000
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2860000
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2998000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12204000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9772000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-384000
us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1700000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3801000
us-gaap Income Taxes Paid
IncomeTaxesPaid
9246000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2795000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
387000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
188000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8815000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
530000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
410000
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
1679000
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-10661000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-45000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-857000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
632000
CY2017Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2016Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
21907000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
140000
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20228000
CY2017Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
191000
CY2016Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
36000
us-gaap Investment Income Interest
InvestmentIncomeInterest
417000
us-gaap Investment Income Interest
InvestmentIncomeInterest
96000
CY2017Q4 us-gaap Liabilities
Liabilities
25610000
CY2017Q1 us-gaap Liabilities
Liabilities
19443000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135591000
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
112809000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
246000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
196000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24934000
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
18355000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12314000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11517000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-564000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9860000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35145000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31642000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
9064000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
4823000
us-gaap Net Income Loss
NetIncomeLoss
27100000
us-gaap Net Income Loss
NetIncomeLoss
16316000
CY2017Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
456000
CY2016Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
166000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1172000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
302000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
10476000
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
8988000
us-gaap Operating Expenses
OperatingExpenses
34756000
us-gaap Operating Expenses
OperatingExpenses
31373000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
11468000
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
7655000
us-gaap Operating Income Loss
OperatingIncomeLoss
38132000
us-gaap Operating Income Loss
OperatingIncomeLoss
25786000
CY2017Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
265000
CY2016Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
755000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
206000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12314000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11632000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
564000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9860000
CY2017Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2017Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
9000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
974000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1019000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29138000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30164000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
72000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
368000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
101287000
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
86530000
CY2017Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
60110000
CY2016Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
52866000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
206478000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
186144000
us-gaap Share Based Compensation
ShareBasedCompensation
1858000
us-gaap Share Based Compensation
ShareBasedCompensation
1444000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
109981000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
93366000
CY2017Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
175000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
0
us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Use of Estimates</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div>
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20425000
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20408000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20437000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20373000
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20368000
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20253000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20337000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20223000

Files In Submission

Name View Source Status
0001437749-18-001323-index-headers.html Edgar Link pending
0001437749-18-001323-index.html Edgar Link pending
0001437749-18-001323.txt Edgar Link pending
0001437749-18-001323-xbrl.zip Edgar Link pending
ex_103678.htm Edgar Link pending
ex_103679.htm Edgar Link pending
ex_103680.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pets-20171231.xml Edgar Link completed
pets-20171231.xsd Edgar Link pending
pets-20171231_cal.xml Edgar Link unprocessable
pets-20171231_def.xml Edgar Link unprocessable
pets-20171231_lab.xml Edgar Link unprocessable
pets-20171231_pre.xml Edgar Link unprocessable
pets20171231_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending